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Engineering a vascularised 3D  
in vitro model of cancer progression
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Mark Emberton2, Marilena Loizidou2 & Umber Cheema1
The hallmark of tumours is the ability of cancerous cells to promote vascular growth, to disseminate and 
invade to distant organs. The metastatic process is heavily influenced by the extracellular matrix (ECM) 
density and composition of the surrounding tumour microenvironment. These microenvironmental 
cues, which include hypoxia, also regulate the angiogenic processes within a tumour, facilitating the 
spread of cancer cells. We engineered compartmentalized biomimetic colorectal tumouroids with 
stromal surrounds that comprised a range of ECM densities, composition and stromal cell populations. 
Recapitulating tissue ECM composition and stromal cell composition enhanced cancer cell invasion. 
Manipulation of ECM density was associated with an altered migration pattern from glandular buds 
(cellular aggregates) to epithelial cell sheets. Laminin appeared to be a critical component in regulating 
endothelial cell morphology and vascular network formation. Interestingly, the disruption of vascular 
networks by cancer cells was driven by changes in expression of several anti-angiogenic genes. Cancer 
cells cultured in our biomimetic tumouroids exhibited intratumoural heterogeneity that was associated 
with increased tumour invasion into the stroma. These findings demonstrate that our 3D in vitro tumour 
model exhibits biomimetic attributes that may permit their use in studying microenvironment clues of 
tumour progression and angiogenesis.
Despite the significant advancements in early diagnostic and therapeutic regimens, the metastatic progression 
of tumours is the leading cause of mortality in colorectal cancer patients1. Tumour progression is mediated by 
microenvironmental conditions that include oxygen gradients between tumour cells in spatially distinct regions, 
cell-cell and cell-extracellular matrix (ECM) interactions2. Understanding the more complex mechanics of 
tumour cell migration within conventional 2D in vitro models has proved challenging and as a result, there has 
recently been an increase in tissue engineered solutions to address this problem3,4. One avenue, not often explored 
within 3D in vitro tumour models, is the effect of the tumour stroma on cancer growth and invasion. ECM density 
and composition are factors that are often overlooked in cancer research but have increasingly been implicated as 
significant factors involved in cancer progression5.
Natural scaffolds are composed of ECM components that make up an interlocking mesh of fibrous proteins 
and glycosaminoglycans (GAGs) including collagens, fibrin and hyaluronic acid6,7. They provide tissues and cells 
with mechanical stability and enable cell-matrix interactions to regulate normal tissue function. Natural scaffolds 
are also biologically active and promote excellent cell adhesion, growth and migration8. When used for in vitro 
3D cell culture, these scaffolds exist as cross-linked networks of ECM proteins known as hydrogels. Although 
one of their main disadvantages is their high water content (upwards of 99%), they are still extremely useful for 
mechanistic investigations as they are entirely malleable by cell behaviour and subject to cell mediated ECM deg-
radation. Increasing the matrix density of these scaffolds can help recreate normal or pathological tissue function.
We engineered tumouroids using colorectal cancer cells (HT29 or HCT116) and cultured them within colla-
gen type I hydrogels. To increase the matrix density and mimic the dense nature of in situ tumours, the interstitial 
fluid within collagen hydrogels was removed using plastic compression (PC)9. Tumouroids are spatially accurate 
and are based on a dense central artificial cancer mass (ACM) that contains the cancer cells, nested within a 
collagen hydrogel that represents the tumour stroma (Fig. 1a). The stromal compartment was populated with the 
basement membrane protein and attachment factor laminin, and stromal cells such as fibroblasts and endothelial 
cells (ECs). The effect of matrix density and composition on cancer invasion was investigated. The development 
of ‘healthy’ and ‘tumourigenic’ vascular networks in the stroma was also explored due to the presence of the 
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endothelium adjacent to a tumour in the in vivo scenario. The current work presented here focuses on developing 
more biomimetic tumour models, which incorporate important aspects of the tumour microenvironment that 
hopefully will shed light on novel mechanisms involved in cancer progression.
Results
Extracellular matrix density and composition of the stroma regulates cancer cell invasion. The 
matrix density of collagen gels was evaluated by freeze-drying acellular collagen gels under a variety of PC meth-
ods. Partially and fully compressed gels were prepared as described previously and were compressed with a 175 g 
weight for a total of 1 minute and 10 minutes10. Partial compression of the collagen gels revealed a 13-fold increase 
(2.63 ± 0.32%) in collagen density in comparison to standard uncompressed collagen gels (0.2%)(p < 0.05)
(Fig. 1b). Full compression using this method revealed a 35-fold increase in collagen density (6.98 ± 1.24%) in 
comparison to collagen hydrogels. RAFT absorbers produced a matrix with a 48-fold increase in collagen density 
(9.59 ± 1.28%) (p < 0.0001) in comparison to uncompressed collagen gels. Uncompressed collagen hydrogels are 
Figure 1. Extracellular matrix density and composition of the stroma regulates cancer cell invasion.  
(a) A schematic diagram illustrating how biomimetic tumouroids are created and the gross appearance of the 
ACM containing HT29 cells nested into the stromal surround, which is either acellular or contains HDFs and 
HUVECs. (b) The matrix densities of collagen gels (n = 4) as a % w/v collagen concentration under different 
compressions, uncompressed, 175 g weight for 1 minute, 175 for 10 minutes and hydrophilic RAFT absorbers 
for 15 minutes. (c) HT29 cells cultured in a high-density collagen matrix (i) invade into a low-density collagen 
stroma and a (ii) low-density collagen and laminin stroma, both as cellular aggregates. (iii) HT29 cell invasion 
switches to an epithelial cell sheet in a high-density collagen matrix stromal surround and (iv) invasion is 
enhanced when laminin is added to the stroma. (d) Quantification of the (i) size of invading cellular aggregates 
and (ii) the distance that cellular aggregates invaded into each respective stromal surround. (e) HCT116 cells 
cultured in a 10% collagen matrix (i) invade into a 0.2% collagen stroma as cell sheets and a (ii) 0.2% collagen 
and laminin hydrogel stromal surround. (iii) HCT116 cells invade into a 10% collagen only stromal surround 
and (iv) enhanced invasion when laminin is present. (f) Quantification of the total distance invaded by HCT116 
cells (i) into a 0.2% collagen stromal surround (ii) and a 10% collagen matrix stromal surround. (g) The different 
morphologies of HT29 and HCT116 cells invading into an acellular stroma. (h) The expression of pro-invasive 
and EMT markers MMP7 and vimentin in 2D monolayers compared to 3D tumouroids cultured for 10 days. 
Data is presented as mean ± SD (n = 6). *p < 0.05. Scale bars – 500 μ m, (magnified views) 100 μ m.
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initially set at ~2.5 mg/ml of collagen, following compression the protein concentration also increases ~48 fold 
to 120 mg/ml.
We engineered ACMs of 10% (w/v) collagen (Fig. 1a and b) containing either HT29 or HCT116 cells embed-
ded in either 0.2% or 10% matrix density stroma. Cells formed cellular aggregates within the ACM mimicking 
avascular micrometastases and invaded the stroma in cell specific patterns (Fig. 1c). HT29 cells invaded as cellular 
aggregates in 10% matrix tumouroids (Fig. 1c). Cellular aggregates detached from the ACM as they migrated 
into the 0.2% collagen stromal surround (Fig. 1ci and ii) forming a network of budding glandular structures 
resembling tumour budding observed at the invasive front of in situ tumours11. The addition of the attachment 
factor and basement membrane (BM) constituent laminin increased the size of the invading aggregates at day 
21 between collagen only (56,615.9 μ m2 ± 28,792.6 μ m2) and collagen and laminin stromal cultures (253,564.6 μ 
m2 ± 115,601.8 μ m2) (Fig. 1di) (p < 0.05) as measured by ImageJ analysis (Supplementary Figure 1). This is likely 
due to the earlier onset of invasion whereby cells migrate to regions of higher nutrients and O2. When the matrix 
density of the surrounding stroma was increased from 0.2% to 10% collagen, HT29 cells demonstrated additional 
migratory patterns (Fig. 1ciii and iv). While cellular aggregates were still distinguishable within the stroma, con-
tiguous cell sheets also invaded from the ACM into the stroma. Invading cellular aggregates displayed a trend of 
migrating further in the dense stromal surround in comparison to hydrogels (Fig. 1dii).
HCT116 cells, which are more metastatic than HT29 cells12, invaded exclusively as epithelial cell sheets 
(Fig. 1e) under all stromal conditions. The presence of invading cell sheets mimics epithelioid neoplastic cell 
sheet invasion at the tumour-stroma boundary in medullary carcinomas, which have an occurrence rate of 5–8 
cases for every 10,000 colorectal cancers diagnosed13. The addition of laminin to the 0.2% collagen stromal cul-
tures increased the overall migration distance of the epithelial cell sheets between day 7 and day 21 in comparison 
to collagen only stromal surrounds (Fig. 1f). Interestingly, when the distances of cell sheet invasion were quan-
tified in different stromal surrounds, highly different patterns of the rate of invasion were observed. In the 0.2% 
collagen stroma, invasion of the cell sheets appeared slow at first, however between day 10 and day 21, the rate of 
invasion increased in a linear fashion. On the contrary, the invasion pattern of HCT116 cells migrating into a 10% 
collagen stromal surround was earlier than the 0.2% collagen stroma. Conversely, at day 14, HCT116 cell sheet 
invasion appears to slow down significantly until day 21 where the presence of laminin appears to be the major 
driving factor in enhancing the total distance migrated.
Invading HT29 cells displayed three different morphologies whereas HCT116 cells displayed only two 
(Fig. 1g). Although the location and morphology of the invading cells appeared random and unsystematic, there 
were distinguishable features to each pattern. In some instances, HT29 cells protruded outwards from the ACM 
into the stromal surround and formed coordinated one-directional organized migration of the invading cell sheet 
(Fig. 1gi). On the other hand, invading HCT116 cell sheets had no structured organization and the migration 
appeared random in all directions (Fig. 1gii). Moreover, the morphology of the cells at the tip of the invading 
sheets differed greatly from those comprising the bulk of the cell sheet. These ‘leader cells’ were particularly 
elongated for both HT29 and HCT116 tumouroids, and appeared morphologically distinct from the cells within 
the ACM (Fig. 1giii and iv). Additionally, HT29 cells also formed cellular aggregates, which completely detached 
from the ACM and invaded into the stroma (Fig. 1gv). This mode of migration was entirely absent from HCT116 
tumouroids.
In order to validate phenotypic changes associated with cancer cell invasion, we examined the presence of 
EMT and MMP expression involved in ECM degradation. Western blotting was used to detect the expression 
patterns of MMP7 and the EMT marker vimentin between cells cultured in 2D and in tumouroids (Fig. 1h). 
Vimentin expression was highly upregulated in both HT29 and HCT116 tumouroids in comparison to their 
monolayer counterparts. The expression level of active MMP7 in HT29 cells was four times higher in tumouroids 
than in 2D. On the other hand, HCT116 tumouroids and 2D monolayers did not illustrate a dramatic difference 
in active MMP7 expression. MMP7 degradation of the β 3 chain in laminin-5 enhances the migration of colorec-
tal cancer cells14, therefore it is possible the upregulation of MMP7 coupled with the presence of laminin in the 
stroma is responsible for the enhanced migratory profile of both HT29 and HCT116 tumouroids. MMP7 over-
expression has been linked to an increased incidence of metastasis and advanced disease in colorectal cancer15,16. 
Although MMPs are typically expressed by stromal cells, MMP7 was chosen due to its established expression 
exclusively by carcinoma cells17.
Disrupted vascular networks in 3D biomimetic tumouroids. To evaluate the vasculogenic potential 
of the ECs, we co-cultured them in either the presence of HDFs only (stromal cultures alone) or HDFs and HT29 
cancer cells (biomimetic tumouroids). In the absence of laminin, ECs formed end-to-end vascular networks in 
the stromal only cultures (Fig. 2a). These vascular networks were longer and wider, but considerably less intercon-
nected than the stromal only cultures in the presence of laminin (Fig. 2b). Vascular networks in the stromal cul-
tures without laminin had a length and width of 290.3 μ m ± 120.7 μ m and 35.9 μ m ± 15.4 μ m respectively whereas 
the presence of laminin led to the formation of vascular networks with a length and width of 197.5 μ m ± 87.5 μ m 
and 19.1 μ m ± 8.1 μ m correspondingly (p < 0.05) (Fig. 2b). Stromal cultures in physiological hypoxia with laminin 
had a similar length and width to the normoxia stromal cultures (215.2 μ m ± 79 μ m and 21.4 μ m ± 7.2 μ m) 
(Fig. 2b). Interestingly, the presence of laminin in the normoxia stromal cultures appeared to produce much more 
significantly interconnected vascular networks as signified by the large number of branches, loops and junctions 
(p < 0.05) (Fig. 2b).
The presence of HT29 cancer cells led ECs to aggregate in a cobblestone pattern within the stroma of the nor-
moxia cultures (Fig. 2c). In addition to the cobblestone morphology, HUVECs formed significantly longer vascu-
lar branches in comparison to the stromal cultures alone (456.8 μ m ± 136 μ m compared to 197.4 μ m ± 87.5 μ m) 
(p < 0.0001) (Fig. 2d). While these tubules were over twice as long, they were significantly less interconnected 
(29.3 ± 3.8 compared to 1.9 ± 1.1 branches) (p < 0.0001). Cobblestone cells formed in large sheets on the apical 
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side of the collagen gel forming a monolayer and strongly expressing membrane bound CD31 while they also 
formed end-to-end networks. These two morphologies mimic developmental mechanisms for tubulogenesis such 
as wrapping and cell hollowing18. This EC morphological heterogeneity is likely due to the chronic exposure to 
pro-angiogenic factors that we have shown before10, which leads to the deregulation of the neovascularization 
process.
We then compared the expression profile of a variety of angiogenic genes between the stroma only cultures 
and the biomimetic tumouroids to elucidate possible differences in gene expression responsible for the forma-
tion/disruption of the formation of vascular networks. Of the 92 genes tested, 5 were differentially expressed in 
both the stromal cultures and the biomimetic tumouroids. Interestingly, MMP2, FBLN5, THBS1, SERPINF1 and 
FN1 were significantly downregulated in biomimetic tumouroids in comparison to the stromal cultures (Fig. 2e). 
Figure 2. Characterization of in vitro healthy and tumourigenic vasculature. (a) HDFs and HUVECs 
(stromal only cultures) were cultured for 21 days under normal atmospheric oxygen (normoxia ~21% O2) 
in 10% collagen gels with and without laminin and in physiological hypoxia (~5% O2) with laminin only. EC 
morphology was assessed using immunofluorescence of CD31 (green) and DAPI (blue). (b) ImageJ was used 
to quantify the length, width, and number of branches, loops and junctions of vascular networks in the stromal 
only cultures. Normoxia cultures without laminin formed longer and wider networks than in the presence of 
laminin, however this may have been due to the presence of the EC cobblestones, which led to a significantly 
lower level of connectivity among the branches. Stromal cultures containing laminin had a significantly higher 
number of branches, loops and junctions in comparison to normoxia without laminin and hypoxia with 
laminin. (c) In the presence of cancer cells (biomimetic tumouroids), ECs formed two distinct morphologies, 
cobblestones and end-to-end vascular networks in the stroma as confirmed by immunofluorescence of CD31 
(green). HT29 cells were stained for CK20 (red) while the unstained nuclei in the stroma are HDFs. (d) ImageJ 
was used to analyze the differences in tubule length and branch connectivity in the presence and absence of 
HT29 cancer cells and showed vascular network integrity was maintained in the absence of HT29 cancer cells. 
(e) Quantitative RT-PCR analysis of angiogenic genes downregulated in biomimetic tumouroids in comparison 
to the stromal only cultures and (f) the expression profiles of angiogenic genes expressed solely in either the 
stroma or in biomimetic tumouroids. Data is presented mean ± SD (n = 6). *p < 0.05, **p < 0.01, ***p < 0.0001. 
Scale bar – 100 μ m.
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Three of these genes, FBLN5, THBS1 and SERPINF1 are important anti-angiogenic factors and are known to 
inhibit tumour growth, increase vascular permeability and decrease vascular sprouting19–21. The most interesting 
of these, SERPINF1, which codes for the Pigment epithelium-derived factor (PEDF), is the most potent inhibitor 
of angiogenesis discovered to date and is twice as potent as angiostatin and seven times more potent than endosta-
tin22. Furthermore, 10 genes were expressed exclusively in biomimetic tumouroids (Fig. 2f), including EDIL3 
which is involved in the formation of complex vascular like structures. Its expression correlates with vascular 
remodelling and poor vascular wall integrity observed in the chick chorioallantoic membrane and functions via 
binding to the α Vβ 3 integrin receptor23. The same study showed that EDIL3 expression entirely prevents ECs 
from forming vascular like structures in vitro. Interestingly, the formation of vascular networks was not entirely 
hindered in our tumouroids and we have previously shown a novel mechanism of vascular network formation 
dependent on α 6 integrin expression. α 6 integrin is critical for cell-laminin attachment and regulates VEGFR2 
levels to promote end to end vascular network formation of ECs in collagen gels24. Furthermore, the qPCR anal-
ysis also revealed the overexpression of two important negative regulators of angiogenesis. ANGPT2 and TIE1 
contribute to normal vascular disruption via inhibition of ANG1 signalling through the formation of a TIE1/TIE2 
heterotypic complex. ANGPT2 and TIE1 are specifically upregulated in tumour vasculature, highlighting the sim-
ilarity in biomarker expression between these 3D biomimetic tumouroids and in vivo tumours25,26.
Tumour heterogeneity and vascular network interactions in 3D biomimetic tumouroids. Tumour 
induced angiogenesis is driven by a series of cell-cell and cell-ECM interactions between cancer cells and ECs. 
Therefore, the following experiments attempted to visualize some of these cell-cell interactions. HT29 cells and 
ECs were stained for CK20 and CD31 respectively. Figure 3a illustrates cell-cell specific interactions between 
the vascular networks and the cancer cells. While the vascular networks in the biomimetic tumouroids did not 
contain any junctions or highly branched networks, they appeared to fork into separate or diverging tubules that 
appeared to grow directly into the invading cell sheet (Fig. 3a, inset).
As solid tumours grow in a 3D spatial configuration, the cells within a tumour are exposed to varying levels 
of oxygen and nutrients. This leads to physical and chemical stresses that regulate differential gene expression of 
cells in different regions within the same tumour. This intratumoural heterogeneity is more analogous to the in 
vivo situation where diffusion limitations result in regions of hypoxic and proliferating cells27. We investigated 
the expression of CK20 as a colorectal cancer marker, which is involved in the identification of normal intestinal 
epithelium and adenocarcinomas and is used routinely in the clinic28. While evaluating the interactions between 
cancer cells and the surrounding vascular networks, we observed the loss of CK20 in some of the invading cell 
sheets within the same tumouroid. However, this was strictly limited to the invading epithelial sheets that had 
migrated the furthest distance from the ACM (Fig. 3c) indicating that loss of CK20 was associated with a signif-
icant increase in the overall distance of cancer cell invasion. This increase in invasion was taken as an indicator 
of tumour aggressiveness. CK20 negative sheets invaded an average distance of 516.6 μ m ± 224.3 μ m whereas 
HT29 cells that retained CK20 expression invaded 254.9 μ m ± 84.3 μ m (p = 0.0089). HT29 aggregates within the 
ACM still expressed strong levels of CK20, highlighting the heterogeneity of protein expression within the same 
tumouroid (Fig. 3b, top left).
Discussion
We have described the development of a 3D in vitro tumour model with controllable parameters including ECM 
density and composition of the tumour and stroma. While cell migration is a highly coordinated process, we 
have shown that in the in vitro setting, it is highly dependent on ECM composition over ECM density. Laminins 
are major regulators of cell adhesion, migration and proliferation24,29. They regulate these cellular processes via 
specific integrin binding sites that switch on mechanotransduction pathways to promote cancer cell invasion. 
Figure 3. Vascular network interaction with cancer cells and intratumoural heterogeneity of biomimetic 
tumouroids. (a) Biomimetic tumouroids were cultured for up to 21 days and stained for CK20 (red), CD31 
(green) and DAPI (blue). Vascular networks appeared to migrate towards the aggressive invading epithelial cell 
sheet tip where they diverged (white arrow, top right panel). Singular tubule branches also migrated towards the 
invaded aggregates within the stroma (white arrow, bottom panel). The white dotted lines denote the boundary 
of the ACM and the stromal surround. (b) CK20 expression was lost in invading HT29 cells and (c) the loss 
of CK20 correlated with the overall distance migrated of the invading epithelial cell sheet. Data is presented as 
mean ± SD (n = 6). *p = 0.0089. Scale bar (top) – 1000 μ m, (bottom) – 100 μ m.
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Specifically, the laminin-5/laminin-332 γ 2 chain has been implicated as an adhesion substrate for epithelial cells 
and is expressed in a wide variety of invasive carcinomas30. Furthermore, the overexpression of the EMT marker 
vimentin and MMP7 suggests that cancer cell invasion in our tumouroids is an active process dependent on the 
proteolysis of the surrounding ECM. To date, most studies have only demonstrated immunohistochemically the 
co-localization or overexpression of specific laminin sub-units at the invasive front of tumours31. While there 
is little mechanistic data directly linking the presence of laminins and increased invasion, our findings are in 
agreement with recent studies showing MMP7 degradation of the β 3 chain in laminin-5/laminin-332 enhanced 
the migration of colorectal adenocarcinoma14. It is likely the upregulation of MMP7 coupled with the addi-
tion of laminin in the stroma is responsible for the enhanced invasion of both HT29 and HCT116 cells in our 
tumouroids.
Surprisingly, it appears the invasion process of cancer cells is driven by several mechanisms simultaneously as 
seen by the presence of glandular structures, polarized collective migration and cell sheets directed by elongated 
cells. The presence of glandular buds mimics what is observed in patients with CRC. Zlobec et al. developed 
an assay using full histopathological data from preoperative biopsies taken from patients with CRC to identify 
whether tumour budding could be used as a predictive method for identifying lymph node and distant metasta-
sis11. Tumour cells isolated from patient biopsies could be cultured in our tumouroid model and graded along-
isde standard histopathological analyses to predict tumour invasiveness. Furthermore, we have also identified 
different mechanisms of migration (glandular buds vs cell sheets) between different colorectal cancer cell lines, 
independent of ECM density or composition, driven in part by a transformation towards a mesenchymal line-
age. Interestingly, elongated cells with a mesenchymal morphology at the edge of the invading cell sheet formed 
cellular protrusions. These leader cells often guide the following cells that compose the main body of the cell 
sheet. The collective migration of these cells did not appear to be driven in a single direction, with the presence 
of many leader cells migrating in random directions and appearing non-polarized. Several recent studies have 
highlighted the importance of these leader cells and their presence on the invasive front, and it is thought that 
they are phenotypically different from follower cells14,32. A recent study by Cheung and colleagues demonstrated 
in a 3D organoid model of breast cancer that collective invasion was led by genotypically distinct cells that were 
defined by their expression of the basal epithelial genes K14 and p6333. They showed that knockdown of either 
K14 or p63 was sufficient enough to block collective invasion. Although, the behaviour of leader cells is not 
well characterized in cancer, it is likely to mimic TGFβ stimulated collective migration which occurs during the 
wound healing process32.
In situ, the metastatic cascade is initiated through a series of interactions between tumour cells and the nearby 
endothelium. While there is no functioning endothelium within our tumouroids, the same cell-cell interactions 
that take place within the in vivo microenvironment between cancer cells and ECs are present, evident by the 
formation of ‘healthy’ and tumourigenic vascular networks. We have shown in this study that vasculogenic and 
angiogenic processes are not entirely mediated by oxygen gradients and the ECM protein laminin is critical in 
regulating EC behaviour. This emphasizes the importance of matrix composition in regulating vasculogenesis 
and angiogenesis. Stamati and colleagues demonstrated end-to-end networks in a model of vasculogenesis in 
collagen hydrogels using HUVECs and human bone marrow derived stem cells (HBMSCs)24. The authors identi-
fied an important link between increased VEGFR2 production on ECs, regulated by HBMSCs, which lead to key 
aggregation patterns in collagen gels in the presence of basement membrane components. It is likely that while 
no HBMSCs were used in this study, the HDFs provided the ECs with a cocktail of angiogenic growth factors to 
generate end-to-end networks. This opens up a new avenue of therapies which may be able to inhibit EC-laminin 
attachment by blocking specific α 6 integrin binding sites.
Intratumoural heterogeneity plays a important role in the clinical outcome of response to therapy34. This 
heterogeneity is complex and poorly understood in the clinic. Therapeutic resistance is mainly caused by the 
presence of many drug-resistant variants of cancer cells within the primary tumour and it has been shown that 
these drug resistant variants are those which repopulate a tumour following neoadjuvent therapy35. In our HT29 
tumouroids, the loss of CK20 expression in the invading epithelial cell sheets strongly correlated with the overall 
distance migrated of the invading sheet indicating that loss of CK20 was associated with tumour aggressiveness. 
Whether the loss of CK20 is a predictive marker for this increased invasiveness or just a by-product of this genetic 
variant is of great importance in understanding the clinical behaviour of colorectal tumours. The loss of CK20 in 
the clinical setting is drastically correlates with microsatellite instability, higher tumour grade, poor differentia-
tion and overall poor survival36,37. We believe that this is the only study to recapitulate the loss of CK20 in CRC 
cell lines and directly correlate it with increased invasion in a 3D in vitro tumour model.
Although our tumouroids lack the full complexity of animal models, this model is cost and time effective, 
allows for easy manipulation of cell and matrix densities and exhibits characteristics of the native in vivo tumour 
microenvironment. Biomimetic 3D tumour models present alternative tools to investigate the effect of multiple 
cell populations and the role of the ECM in cancer progression.
Materials and Methods
Cell Culture. The HT29 human colorectal adenocarcinoma cell line and the HCT116 human colorectal car-
cinoma cell lines were obtained from the European Collection of Cell Cultures (Sigma Aldrich, Dorset, UK). 
Human umbilical vein endothelial cells (HUVECs) were purchased from Promocell (Heidelberg, Germany) and 
Human dermal fibroblasts (HDFs) from Invitrogen (Paisley, UK). HT29 and HCT116 cells were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 1 g/L glucose, 10% FBS, 100 units/ml penicillin 
and 100 μ g/ml streptomycin (all from Invitrogen, Paisley, UK). HUVECs were cultured in complete endothe-
lial growth medium (EGM) (Promocell, Heidelberg, Germany) supplemented with 10% FBS and 100 units/ml 
penicillin and 100 μ g/ml streptomycin. HDFs were cultured in high glucose (5 g/L) DMEM supplemented with 
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10% FBS and 100 units/ml penicillin and 100 μ g/ml streptomycin. All cell types were routinely maintained as 2D 
monolayers at 37 °C in standard cell culture conditions (5% CO2/air and 95% humidity).
Fabrication of 3D biomimetic tumouroids. The ACMs were prepared using the RAFT™ 3D cell culture 
system (Lonza, Slough, UK) as described previously38. Briefly, 2.8 ml of 10X minimum essential medium (MEM) 
was added to 22.4 ml rat-tail collagen type I (2.05 mg/ml in 0.6% acetic acid). This was neutralized with 1.6 ml 
of the Neutralizing Solution before 1.2 ml of the cancer cell suspension (HT29 or HCT116) at a concentration 
of 4.96 × 106 cells/ml, was added and mixed thoroughly. Gels were cast in 96 well plates (240 μ l) and placed on a 
plate heater (Sartorius, Royston, UK) set at 37 °C for 15 minutes. Each ACM contained 50,000 HT29 or HCT116 
cells per well (208,000 cells/ml). Biocompatible hydrophilic RAFT absorbers were placed on the gels for 15 min-
utes to remove the interstitial fluid from the collagen gels. The absorbers were removed, 100 μ l of culture medium 
was added to the wells and the plate was returned to the incubator (37 °C, 5% CO2/air and 95% humidity).
To incorporate laminin into the acellular stroma, 50 μ g/ml of laminin (BD Biosciences) was added to the 
collagen-MEM mixture prior to neutralization. This concentration was based on published literature24. Briefly, 
500 μ l of neutralized acellular collagen ± laminin was cast in 24 well plates and allowed to gel for 5 minutes on 
a plate heater at 37 °C. Each ACM was then removed manually from their 96-well plate then placed on the gel 
before 500 μ l of acellular neutralized collagen ± laminin was added on top to fully immerse the ACM. This was 
allowed to gel for 10 minutes at 37 °C. These cultures were used as 0.2% cultures. For 10% matrix cultures the 
interstitial fluid was removed using hydrophilic RAFT absorbers and the tumouroids were immersed in DMEM.
To engineer the cellular stroma, HUVECs and HDFs were added to the neturalized collagen-laminin solution 
at a concentration of 50,000 and 25,000 cells respectively per single tumouroid resulting in ratio of 8:2:1 for HT29, 
HUVEC and HDF cells (Fig. 1a).
Stromal only cultures were fabricated with the same ratio of 2:1 of HUVECs to HDFs in the absence of ACMs. 
Finally, 1 ml of DMEM and EGM mix (1:1) was added to each well and returned to the incubator. Experiments 
carried out in physiological hypoxia were carried out in a separate incubator set at 37 °C, 5% CO2, 5% O2 and 
90% N2. Physiological hypoxia is also known as ‘in situ normoxia’ and is representative of the normal O2 pressure 
present within tissues.
Immunofluorescence. Tumouroids were fixed using 10% formalin for 30 minutes and washed with PBS. 
After permeabilising with 0.2% TX- 100 for 30 minutes, the gels were washed thoroughly with PBS (3 × 5 min-
utes) and blocked with 1% BSA for 30 minutes. After washing with PBS, gels were incubated with either a CK20 
rabbit primary antibody (D9Z1Z from New England Biolabs, Herts, UK) or an anti-CD31 mouse primary anti-
body (JC70/A from Abcam, Cambridge, UK) overnight at 4 °C. After washing thoroughly, gels were incubated 
with an Alexa Fluor 488 goat anti mouse IgG secondary antibody (Invitrogen, Paisley, UK) and DyLight 594 
goat anti-rabbit IgG secondary antibody (Vector labs, Peterborough, UK) for 2.5 hours at room temperature. The 
actin filaments were stained with Rhodamine Phalloidin conjugated to an Alexa Fluor® 488 fluorescent anti-
body (Invitrogen) for 1 hour at room temperature. The gels were then washed with PBS thoroughly and 2 drops 
of NucBlu (Invitrogen, Paisley, UK) was added to the PBS in each sample. Tumouroids were imaged using an 
inverted EVOS® FL imaging microscope (Invitrogen).
Collagen gel density measurement. The density of collagen gels was assessed using the freeze-drying 
method. Acellular collagen gels were prepared and compressed under various weights. Collagen gels (uncom-
pressed), partially compressed gels (compressed with 175 g weight for 1 minute), fully compressed gels (com-
pressed with 175 g weight for 10 minutes) and RAFT gels (removal of interstitial fluid using hydrophilic RAFT 
absorbers for 15 minutes). Once the gels were prepared, DMEM was added to each sample for 24 hours to accom-
modate a bounce back effect from the collagen gels (reabsorption of fluid). The gels were then washed with 
PBS followed by a thorough wash in distilled water in until all the salts within the gel were removed. This was 
estimated by a colour change of the collagen gel from pink to colourless. The gel weight was then measured 
using a balance to calculate the wet weight of the gel. Each gel was then frozen at − 20 °C for 1 hour before being 
freeze-dried overnight and the weight of the dry gels was measured again. The difference between the wet and dry 
weights was then used to calculate the overall collagen content within the gels once the water had been removed.
Western blotting. Cells were extracted from tumouroids using 500 units/ml collagenase (Sigma Aldrich) 
for 1 hour at 37 °C. Cells in 2D and 3D were lysed in RIPA buffer containing protease inhibitors (Sigma) and 
quantified using the Pierce™ Modified Lowry Protein Assay Kit (Thermo Scientific) according to the manu-
facturers protocol. Equal amounts of protein (35 μ g) were loaded in gels (BioRad), resolved by SDS-PAGE and 
transferred to PVDF membranes. Membranes were blocked for 30 minutes in 2.5% BSA and 0.05% Tween 20 in 
PBS. Antigens were detected using mouse monoclonal antibodies against MMP-7 and vimentin (both at 1:1,000, 
Santa-Cruz Biotechnology, Santa Cruz, CA) and incubated with a goat anti-mouse IgG-HRP (Santa Cruz) sec-
ondary antibody at room temperature for 30 minutes. Blots were developed using the Clarity™ Western ECL 
Substrate (Bio-Rad, Hertfordshire) and visualized using the ChemiDoc™ XRS+ System (Bio-Rad).
Real-time angiogenesis PCR array. Total RNA was isolated from stromal only cultures (HDFs and 
HUVECs only) and biomimetic tumouroids (ACM and stroma) using TRI Reagent® (Sigma) according to 
the manufacturers instructions. Total RNA was quantified using a nanodrop spectrophotometer measur-
ing at 260/280 nm. cDNA was synthesized using the High Capacity cDNA Reverse Transcription kit (Applied 
Biosystems) according to the manufacturers instructions. Gene expression analysis was conducted using the 
TaqMan® Human Angiogenesis PCR array (Applied Biosystems). This assay contains 92 genes related to angi-
ogenesis and lymphangiogenesis (see www.thermofisher.com for a full list of the genes). Gene expression lev-
els were measured by RT-PCR using the CFX96 Touch system (Bio-Rad) following the array manufacturers 
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instructions. Relative gene expression was calculated using the 2-Δ CT method. Changes in gene expression 
are presented as fold increase/decrease normalized to the average CT value for the endogenous reference 
genes Beta-glucuronidase (GUSB), 18S ribosomal RNA (18S) and Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH).
Statistical analysis. The data presented throughout are displayed as the mean ± standard deviation (SD) 
and was calculated using GraphPad Prism 6 software (GraphPad, San Diego, CA). Statistical analysis was car-
ried out on original data values where the data was converted to percentages or fold increases/decreases. Data 
points (n numbers) are displayed for each respective experiment in the figure legend. Data comparisons for 
two sets of data were analyzed for statistical significance by Students t-test analysis. Vascular network analysis 
(Supplementary Figure 1c) among different groups was carried out using one-way analysis of variance (ANOVA) 
followed by post hoc analysis using Tukeys multiple comparisons test. Gene expression analysis was conducted 
using two-way ANOVA followed by post hoc analysis using Sidak’s multiple comparisons test. Significance was 
taken at or below p < 0.05.
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